“Increasing Old Age Population”
The burgeoning global aging population is having a profound impact on the rectocele treatment market. With the number of individuals aged 60 and older projected to swell to 2.1 million by 2050, the incidence of rectocele—an ailment more prevalent among older women—is expected to increase significantly. Such demographic shift is catalyzing a notable expansion in market demand, as the rising prevalence of rectocele necessitates more specialized treatments and healthcare interventions. The growing elderly population is thus driving market growth by broadening the patient base and spurring advancements in treatment options tailored to age-related needs. Such trend is prompting healthcare providers to innovate and enhance their service offerings to effectively address the escalating demand for rectocele management solutions.
